MCM
EXAS

MAI Capital Management’s Exact Sciences EXAS Stock Holding History

MAI Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,500
Closed -$118K – 463
2018
Q3 		$118K Buy
+1,500
New +$97.8K 0.01% 465

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

MAI Capital Management's EXAS Position: Q1 2026 in Review

MAI Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 585 shares — an estimated $59.4K sold.

MAI Capital Management first reported a position in EXAS in Q3 2018 and held it in 9 quarters. The position peaked at $250K in Q1 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • MAI Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • MAI Capital Management sold 585 Exact Sciences shares in Q1 2026, an estimated $59.4K.
  • MAI Capital Management first reported a position in Exact Sciences in Q3 2018 and held it in 9 quarters.
  • MAI Capital Management's Exact Sciences position peaked at $250K in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.